These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3926447)

  • 21. Ticlopidine in the treatment of peripheral occlusive arterial disease.
    Arcan JC; Panak E
    Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
    [No Abstract]   [Full Text] [Related]  

  • 22. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
    Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D
    Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
    Charansonney OL; Spriet A
    Therapie; 1995; 50(1):73-8. PubMed ID: 7754482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline in arterial disease of the legs.
    Verhaeghe R; Verstraete M
    Eur J Clin Pharmacol; 1991; 41(6):507-9. PubMed ID: 1815961
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B
    Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
    Ehrly AM; Saeger-Lorenz K
    Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
    Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
    Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Roset PN
    Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
    [No Abstract]   [Full Text] [Related]  

  • 32. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug committee on peripheral arterial occlusive disease. New guidelines for intermittent claudication].
    Füessl HS
    MMW Fortschr Med; 2000 Sep; 142(39):4-6. PubMed ID: 11072691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Design and method of clinical trials of drugs used in the therapy of stable peripheral arterial occlusive disease].
    Wink K
    Arzneimittelforschung; 2006; 56(1):52-7. PubMed ID: 16478006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 36. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intermittent claudication. Attempt at an objective vue of the disease and the possible treatment results with Sibelium].
    Loots W; Dom J; Hörig C
    Med Welt; 1980 Feb; 31(5):189-92. PubMed ID: 7366398
    [No Abstract]   [Full Text] [Related]  

  • 38. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
    [No Abstract]   [Full Text] [Related]  

  • 39. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
    Komarov AL; Panchenko EP; Eshkeeva AR; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA
    Ter Arkh; 1996; 68(2):49-53. PubMed ID: 8771659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
    Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.